Corient Private Wealth’s Globe Life GL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21M Sell
6,466
-345,896
-98% -$48.8M ﹤0.01% 1539
2025
Q4
$47.6M Buy
352,362
+86,300
+32% +$11.7M 0.03% 371
2025
Q3
$35.5M Buy
266,062
+23,827
+10% +$3.23M 0.06% 287
2025
Q2
$30.1M Sell
242,235
-67,466
-22% -$8.19M 0.04% 311
2025
Q1
$40.8M Sell
309,701
-58,225
-16% -$7.12M 0.07% 261
2024
Q4
$41M Sell
367,926
-11,012
-3% -$1.19M 0.07% 256
2024
Q3
$40.1M Buy
378,938
+23,077
+6% +$2.21M 0.06% 279
2024
Q2
$29.3M Sell
355,861
-8,995
-2% -$745K 0.05% 313
2024
Q1
$42.5M Buy
364,856
+2,321
+0.6% +$284K 0.08% 251
2023
Q4
$44.1M Buy
362,535
+337,836
+1,368% +$39.7M 0.08% 237
2023
Q3
$2.69M Buy
24,699
+257
+1% +$28.7K 0.01% 812
2023
Q2
$2.68M Buy
24,442
+297
+1% +$31.9K 0.01% 814
2023
Q1
$2.66M Buy
24,145
+21,781
+921% +$2.56M 0.01% 758
2022
Q4
$285K Buy
+2,364
New +$270K ﹤0.01% 1355

Other funds holding GL

Corient Private Wealth's GL Position: Q1 2026 in Review

Corient Private Wealth reduced its Globe Life (GL) stake by 98% in Q1 2026, selling an estimated $48.8M and leaving 6,466 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1539.

Corient Private Wealth first reported a position in GL in Q4 2022 and has held it in 14 quarters since. The position peaked at $47.6M in Q4 2025. 663 funds tracked by Wall St. Rank hold GL as of Q1 2026.

  • Corient Private Wealth held 6,466 shares of Globe Life worth $1.21M as of Q1 2026.
  • Corient Private Wealth sold 345,896 Globe Life shares in Q1 2026, an estimated $48.8M.
  • Globe Life made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1539 holding.
  • Corient Private Wealth first reported a position in Globe Life in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Globe Life position peaked at $47.6M in Q4 2025.
  • 663 funds tracked by Wall St. Rank held Globe Life as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.